300298 三诺生物
已收盘 04-28 15:00:00
资讯
新帖
简况
【三诺生物:2024年归母净利润3.26亿元,同比增长14.73%】三诺生物4月20日公告,2024年实现营业收入44.43亿元,同比增长9.47%;归属于上市公司股东的净利润3.26亿元,同比增长14.73%;基本每股收益0.589元。公司拟向全体股东每10股派发现金股利2.2元。本次利润分配不送红股,不进行资本公积金转增股本,剩余未分配利润结转下一年度。
金融界 · 04-20
【三诺生物:2024年归母净利润3.26亿元,同比增长14.73%】三诺生物4月20日公告,2024年实现营业收入44.43亿元,同比增长9.47%;归属于上市公司股东的净利润3.26亿元,同比增长14.73%;基本每股收益0.589元。公司拟向全体股东每10股派发现金股利2.2元。本次利润分配不送红股,不进行资本公积金转增股本,剩余未分配利润结转下一年度。
图解三诺生物年报:第四季度单季净利润同比增310.96%
证券之星 · 04-20
图解三诺生物年报:第四季度单季净利润同比增310.96%
三诺生物(300298.SZ)发布2024年度业绩,归母净利润3.26亿元,同比增长14.73%
智通财经 · 04-20
三诺生物(300298.SZ)发布2024年度业绩,归母净利润3.26亿元,同比增长14.73%
三诺生物获得外观设计专利授权:“持续葡萄糖监测穿刺针”
证券之星 · 03-10
三诺生物获得外观设计专利授权:“持续葡萄糖监测穿刺针”
三诺生物新提交“三诺”商标注册申请
证券之星 · 03-02
三诺生物新提交“三诺”商标注册申请
“顶流”调仓路径曝光:谢治宇建仓吉祥航空,冯明远调仓英集芯,赵枫减持三诺生物
华夏时报 · 02-28
“顶流”调仓路径曝光:谢治宇建仓吉祥航空,冯明远调仓英集芯,赵枫减持三诺生物
三诺生物新注册《安稳+系列血糖仪软件V1.0》项目的软件著作权
证券之星 · 02-25
三诺生物新注册《安稳+系列血糖仪软件V1.0》项目的软件著作权
三诺生物最新公告:拟以1.5亿元-3亿元回购股份
证券之星 · 02-20
三诺生物最新公告:拟以1.5亿元-3亿元回购股份
三诺生物公告,拟以1.5亿元-3亿元回购股份,回购价格不超过人民币34元/股。
美港电讯 · 02-20
三诺生物公告,拟以1.5亿元-3亿元回购股份,回购价格不超过人民币34元/股。
2月18日三诺生物跌6.44%,睿远成长价值混合A基金重仓该股
证券之星 · 02-18
2月18日三诺生物跌6.44%,睿远成长价值混合A基金重仓该股
2月14日三诺生物涨13.04%,睿远成长价值混合A基金重仓该股
证券之星 · 02-14
2月14日三诺生物涨13.04%,睿远成长价值混合A基金重仓该股
三诺生物涨13.04%,国金证券一个月前给出“买入”评级
证券之星 · 02-14
三诺生物涨13.04%,国金证券一个月前给出“买入”评级
A股医疗器械板块盘初强势,超妍股份涨超11%,安必平涨超10%,达安基因封板涨停, 华大智造涨超7%,爱朋医疗、三诺生物
美港电讯 · 02-14
A股医疗器械板块盘初强势,超妍股份涨超11%,安必平涨超10%,达安基因封板涨停, 华大智造涨超7%,爱朋医疗、三诺生物
三诺生物(300298)2月12日主力资金净流入1311.82万元
金融界 · 02-12
三诺生物(300298)2月12日主力资金净流入1311.82万元
三诺生物新注册《SC801 Air血糖仪软件V1.0》项目的软件著作权
证券之星 · 02-10
三诺生物新注册《SC801 Air血糖仪软件V1.0》项目的软件著作权
三诺生物新注册《持续葡萄糖监测系统BM发射器软件V1.0》项目的软件著作权
证券之星 · 01-24
三诺生物新注册《持续葡萄糖监测系统BM发射器软件V1.0》项目的软件著作权
三诺生物新注册《Reader软件V1.0》项目的软件著作权
证券之星 · 01-20
三诺生物新注册《Reader软件V1.0》项目的软件著作权
加载更多
公司概况
公司名称:
三诺生物传感股份有限公司
所属行业:
专用设备制造业
上市日期:
2012-03-19
主营业务:
三诺生物传感股份有限公司的主营业务是血糖监测系统的生产和销售。公司的主要产品是血糖监测系统、糖尿病营养、护理等辅助产品、血脂检测系统、iPOCT监测系统、糖化血红蛋白检测系统、血压计、经营品。公司作为血糖监测领域领先企业,先后荣获“国家企业技术中心”、“国家工程研究中心”、“国家技术创新示范企业”、“国家知识产权优势企业”、“国家科技进步二等奖”和“国家绿色工厂”等资质。
发行价格:
29.00
{"stockData":{"symbol":"300298","market":"SZ","secType":"STK","nameCN":"三诺生物","latestPrice":21.75,"timestamp":1745823789000,"preClose":21.85,"halted":0,"volume":4973210,"delay":0,"changeRate":-0.0046,"floatShares":455000000,"shares":564000000,"eps":0.6526,"marketStatus":"已收盘","change":-0.1,"latestTime":"04-28 15:00:00","open":21.7,"high":22.02,"low":21.4,"amount":108000000,"amplitude":0.0284,"askPrice":21.75,"askSize":21,"bidPrice":21.74,"bidSize":166,"shortable":0,"etf":0,"ttmEps":0.6526,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745890200000},"marketStatusCode":5,"adr":0,"adjPreClose":21.85,"symbolType":"stock","openAndCloseTimeList":[[1745803800000,1745811000000],[1745816400000,1745823600000]],"highLimit":24.04,"lowLimit":19.67,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":564265375,"isCdr":false,"pbRate":3.81,"roa":"--","peRate":33.328226,"roe":"10.3%","epsLYR":0.589,"committee":0.525652,"marketValue":12273000000,"turnoverRate":0.0109,"status":1,"floatMarketCap":9903000000},"requestUrl":"/m/hq/s/300298","defaultTab":"news","newsList":[{"id":"2528355854","title":"【三诺生物:2024年归母净利润3.26亿元,同比增长14.73%】三诺生物4月20日公告,2024年实现营业收入44.43亿元,同比增长9.47%;归属于上市公司股东的净利润3.26亿元,同比增长14.73%;基本每股收益0.589元。公司拟向全体股东每10股派发现金股利2.2元。本次利润分配不送红股,不进行资本公积金转增股本,剩余未分配利润结转下一年度。","url":"https://stock-news.laohu8.com/highlight/detail?id=2528355854","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528355854?lang=zh_cn&edition=full","pubTime":"2025-04-20 16:48","pubTimestamp":1745138918,"startTime":"0","endTime":"0","summary":"三诺生物4月20日公告,2024年实现营业收入44.43亿元,同比增长9.47%;归属于上市公司股东的净利润3.26亿元,同比增长14.73%;基本每股收益0.589元。公司拟向全体股东每10股派发现金股利2.2元。本次利润分配不送红股,不进行资本公积金转增股本,剩余未分配利润结转下一年度。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/20164849694948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300298"],"gpt_icon":0},{"id":"2528516288","title":"图解三诺生物年报:第四季度单季净利润同比增310.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528516288","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528516288?lang=zh_cn&edition=full","pubTime":"2025-04-20 16:42","pubTimestamp":1745138548,"startTime":"0","endTime":"0","summary":"证券之星消息,三诺生物2024年年报显示,公司主营收入44.43亿元,同比上升9.47%;归母净利润3.26亿元,同比上升14.73%;扣非净利润2.95亿元,同比上升0.65%;其中2024年第四季度,公司单季度主营收入12.61亿元,同比上升23.22%;单季度归母净利润7094.88万元,同比上升310.96%;单季度扣非净利润6299.61万元,同比上升235.25%;负债率38.18%,投资收益-159.54万元,财务费用2007.22万元,毛利率54.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042000002460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298"],"gpt_icon":0},{"id":"2528513378","title":"三诺生物(300298.SZ)发布2024年度业绩,归母净利润3.26亿元,同比增长14.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528513378","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528513378?lang=zh_cn&edition=full","pubTime":"2025-04-20 16:35","pubTimestamp":1745138140,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三诺生物(300298.SZ)披露2024年年度报告,报告期公司实现营收44.43亿元,同比增长9.47%;归母净利润3.26亿元,同比增长14.73%;扣非净利润2.95亿元,同比增长0.65%;基本每股收益0.589元。公司拟向全体股东每10股派发现金股利2.20元人民币(含税)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1281199.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300298"],"gpt_icon":0},{"id":"2518204350","title":"三诺生物获得外观设计专利授权:“持续葡萄糖监测穿刺针”","url":"https://stock-news.laohu8.com/highlight/detail?id=2518204350","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518204350?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:10","pubTimestamp":1741633828,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示三诺生物新获得一项外观设计专利授权,专利名为“持续葡萄糖监测穿刺针”,专利申请号为CN202430377508.8,授权日为2025年3月11日。今年以来三诺生物新获得专利授权13个,较去年同期增加了85.71%。结合公司2024年中报财务数据,2024上半年公司在研发方面投入了1.71亿元,同比增6.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025031100002230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0251","BK0114","300298"],"gpt_icon":0},{"id":"2516542036","title":"三诺生物新提交“三诺”商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2516542036","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516542036?lang=zh_cn&edition=full","pubTime":"2025-03-03 05:16","pubTimestamp":1740950183,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日三诺生物传感股份有限公司新提交“三诺”商标注册申请。商标申请详情如下:今年以来三诺生物传感股份有限公司新申请注册商标3件,截止目前公司共持有注册商标899件,另有367件商标尚在注册申请中。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030300000929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0251","BK0102","BK0114"],"gpt_icon":0},{"id":"2516583563","title":"“顶流”调仓路径曝光:谢治宇建仓吉祥航空,冯明远调仓英集芯,赵枫减持三诺生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2516583563","media":"华夏时报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516583563?lang=zh_cn&edition=full","pubTime":"2025-03-01 07:15","pubTimestamp":1740784500,"startTime":"0","endTime":"0","summary":"公告显示,冯明远调仓英集芯,谢治宇建仓吉祥航空。其中,睿远基金傅鹏博稍增持三诺生物,赵枫反而减持。2月24日,三诺生物发布回购股份公告。其中披露了截至2月19日前十名股东和前十名流通股东的持股情况。而根据该基金2024年第四季度报告,奥浦迈是该基金第三大重仓股,较去年第三季度末,陆彬减持了17.53%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-03-01/doc-inencaap6239357.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-03-01/doc-inencaap6239357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0185","BK0251","BK0102","BK0214","300298","603885","BK0280","688209","BK0114"],"gpt_icon":0},{"id":"2514012006","title":"三诺生物新注册《安稳+系列血糖仪软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2514012006","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514012006?lang=zh_cn&edition=full","pubTime":"2025-02-26 01:33","pubTimestamp":1740504790,"startTime":"0","endTime":"0","summary":"证券之星消息,近日三诺生物(300298)新注册了《安稳+系列血糖仪软件V1.0》项目的软件著作权。今年以来三诺生物新注册软件著作权4个,较去年同期增加了33.33%。结合公司2024年中报财务数据,2024上半年公司在研发方面投入了1.71亿元,同比增6.14%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022600000473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0114","BK0102","300298"],"gpt_icon":0},{"id":"2512844560","title":"三诺生物最新公告:拟以1.5亿元-3亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2512844560","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512844560?lang=zh_cn&edition=full","pubTime":"2025-02-20 19:40","pubTimestamp":1740051659,"startTime":"0","endTime":"0","summary":"三诺生物公告称,公司拟使用自有资金及银行回购专项贷款,以集中竞价交易方式回购部分社会公众股,回购价格不超过34.00元/股,资金总额不低于1.5亿元且不超过3亿元。回购股份将用于员工持股计划、股权激励或转换可转债。公司已取得中国民生银行长沙分行的贷款承诺函,同意提供不超过2.7亿元的股票回购贷款。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022000034098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0114","300298","BK0102"],"gpt_icon":0},{"id":"2512443658","title":"三诺生物公告,拟以1.5亿元-3亿元回购股份,回购价格不超过人民币34元/股。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512443658","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512443658?lang=zh_cn&edition=full","pubTime":"2025-02-20 19:26","pubTimestamp":1740050772,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0114","BK0102","300298","BK0251"],"gpt_icon":0},{"id":"2512136331","title":"2月18日三诺生物跌6.44%,睿远成长价值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2512136331","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512136331?lang=zh_cn&edition=full","pubTime":"2025-02-18 16:25","pubTimestamp":1739867122,"startTime":"0","endTime":"0","summary":"证券之星消息,2月18日三诺生物跌6.44%,收盘报25.14元,换手率3.74%,成交量17.02万手,成交额4.35亿元。重仓三诺生物的前十大公募基金请见下表:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为33.96。根据2024基金年报公募基金重仓股数据,重仓该股的公募基金共26家,其中持有数量最多的公募基金为睿远成长价值混合A。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021800027807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0114","BK0102","300298"],"gpt_icon":0},{"id":"2511659434","title":"2月14日三诺生物涨13.04%,睿远成长价值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2511659434","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511659434?lang=zh_cn&edition=full","pubTime":"2025-02-14 16:24","pubTimestamp":1739521467,"startTime":"0","endTime":"0","summary":"证券之星消息,2月14日三诺生物涨13.04%,收盘报26.44元,换手率6.89%,成交量31.36万手,成交额8.08亿元。重仓三诺生物的前十大公募基金请见下表:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为33.96。根据2024基金年报公募基金重仓股数据,重仓该股的公募基金共26家,其中持有数量最多的公募基金为睿远成长价值混合A。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021400025510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0114","BK0102","300298"],"gpt_icon":0},{"id":"2511265949","title":"三诺生物涨13.04%,国金证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2511265949","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511265949?lang=zh_cn&edition=full","pubTime":"2025-02-14 16:24","pubTimestamp":1739521460,"startTime":"0","endTime":"0","summary":"今日三诺生物涨13.04%,收盘报26.44元。2024年12月17日,国金证券研究员袁维,何冠洲发布了对三诺生物的研报《新一代CGM国内获批,产品升级迭代加速》,该研报对三诺生物给出“买入”评级。研报中预计2024-2026年公司归母净利润分别为3.68、5.07、6.37亿元,同比增长30%、38%、26%,现价对应PE为41、30、24倍,维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为73.36%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021400025499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298"],"gpt_icon":0},{"id":"2511825683","title":"A股医疗器械板块盘初强势,超妍股份涨超11%,安必平涨超10%,达安基因封板涨停, 华大智造涨超7%,爱朋医疗、三诺生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2511825683","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511825683?lang=zh_cn&edition=full","pubTime":"2025-02-14 09:36","pubTimestamp":1739496991,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0251","688114","399300","BK0122","BK0102","BK1222","BK0159","BK1100","BK0239","BK0046","BK0028","BK0168","159982","BK0042","002030","BK1583","BK0114","BK1574","688393","BK0188","159883","300298","09997","300753","09996"],"gpt_icon":0},{"id":"2510326414","title":"三诺生物(300298)2月12日主力资金净流入1311.82万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510326414","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510326414?lang=zh_cn&edition=full","pubTime":"2025-02-12 17:53","pubTimestamp":1739354038,"startTime":"0","endTime":"0","summary":"金融界消息 截至2025年2月12日收盘,三诺生物报收于23.33元,上涨0.21%,换手率1.08%,成交量4.93万手,成交金额1.14亿元。资金流向方面,今日主力资金净流入1311.82万元,占比成交额11.47%。三诺生物最新一期业绩显示,截至2024三季报,公司营业总收入31.82亿元、同比增长4.83%,归属净利润2.55亿元,同比减少19.71%,扣非净利润2.32亿元,同比减少31.73%,流动比率1.416、速动比率0.980、资产负债率39.74%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/12175348116096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0114","BK0251","300298","BK0102"],"gpt_icon":0},{"id":"2510874893","title":"三诺生物新注册《SC801 Air血糖仪软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2510874893","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510874893?lang=zh_cn&edition=full","pubTime":"2025-02-11 01:38","pubTimestamp":1739209093,"startTime":"0","endTime":"0","summary":"证券之星消息,近日三诺生物(300298)新注册了《SC801 Air血糖仪软件V1.0》项目的软件著作权。今年以来三诺生物新注册软件著作权3个,较去年同期减少了0%。结合公司2024年中报财务数据,2024上半年公司在研发方面投入了1.71亿元,同比增6.14%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021100000431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0114","300298","BK0251"],"gpt_icon":0},{"id":"2506895130","title":"三诺生物新注册《持续葡萄糖监测系统BM发射器软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2506895130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506895130?lang=zh_cn&edition=full","pubTime":"2025-01-25 01:26","pubTimestamp":1737739576,"startTime":"0","endTime":"0","summary":"证券之星消息,近日三诺生物(300298)新注册了《持续葡萄糖监测系统BM发射器软件V1.0》项目的软件著作权。今年以来三诺生物新注册软件著作权2个,较去年同期增加了100%。结合公司2024年中报财务数据,2024上半年公司在研发方面投入了1.71亿元,同比增6.14%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012500002396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","300298","BK0251","BK0114"],"gpt_icon":0},{"id":"2505233213","title":"三诺生物新注册《Reader软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2505233213","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505233213?lang=zh_cn&edition=full","pubTime":"2025-01-21 01:15","pubTimestamp":1737393316,"startTime":"0","endTime":"0","summary":"证券之星消息,近日三诺生物(300298)新注册了《Reader软件V1.0》项目的软件著作权。今年以来三诺生物新注册软件著作权1个。结合公司2024年中报财务数据,2024上半年公司在研发方面投入了1.71亿元,同比增6.14%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012100000351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","300298","BK0114","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1745844511407,"stockEarnings":[{"period":"1week","weight":0.0817},{"period":"1month","weight":-0.0734},{"period":"3month","weight":-0.031},{"period":"6month","weight":-0.2092},{"period":"1year","weight":-0.0498},{"period":"ytd","weight":-0.1534}],"compareEarnings":[{"period":"1week","weight":0.0056},{"period":"1month","weight":-0.0219},{"period":"3month","weight":0.013},{"period":"6month","weight":-0.0014},{"period":"1year","weight":0.0793},{"period":"ytd","weight":-0.0169}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"三诺生物传感股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"16418人(较上一季度增加26.02%)","perCapita":"27731股","listingDate":"2012-03-19","address":"湖南省长沙市岳麓区高新技术产业开发区谷苑路265号","registeredCapital":"56426万元","survey":" 三诺生物传感股份有限公司的主营业务是血糖监测系统的生产和销售。公司的主要产品是血糖监测系统、糖尿病营养、护理等辅助产品、血脂检测系统、iPOCT监测系统、糖化血红蛋白检测系统、血压计、经营品。公司作为血糖监测领域领先企业,先后荣获“国家企业技术中心”、“国家工程研究中心”、“国家技术创新示范企业”、“国家知识产权优势企业”、“国家科技进步二等奖”和“国家绿色工厂”等资质。","listedPrice":29},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三诺生物(300298)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三诺生物(300298)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三诺生物,300298,三诺生物股票,三诺生物股票老虎,三诺生物股票老虎国际,三诺生物行情,三诺生物股票行情,三诺生物股价,三诺生物股市,三诺生物股票价格,三诺生物股票交易,三诺生物股票购买,三诺生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三诺生物(300298)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三诺生物(300298)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}